08
Apr
Apr
The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.Read more…Read More
Tag Archives: Ozempic
02
Apr
Apr
As semaglutide-based weight loss treatments, such as Ozempic and Wegovy, become more popular, new side effects are emerging – and one is hair loss…Read More
28
Mar
Mar
In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions left to answer, not least what the future holds for weight-loss medications and society at large…Read More
15
Mar
Mar
RNS) — Not if taken for the right reasons, say Islamic scholars and doctors. The post Is taking Ozempic during Ramadan cheating? appeared first on RNS…Read More
09
Mar
Mar
Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why…Read More
09
Mar
Mar
Read more…Read More
09
Mar
Mar
Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority of people who use these drugs quit after just two years…Read More
23
Feb
Feb
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…Read More
23
Feb
Feb
The real cost? Your medical license…Read More
23
Feb
Feb
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these figures provides insight into the shifting landscape of the pharmaceutical industry, including the rise of weight-loss drugs, the shrinking demand of COVID-19 vaccines, and the necessity of…Read more…Read More
